MicroRNA200a enhances antitumor effects in combination with doxorubicin in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is often treated with doxorubicin. MicroRNAs have been shown to have important regulatory roles in cancer and serve as a target in chemoresistance. In this study, we investigated the effects of specific microRNA-200a (miR-200a) on HCC tumor cell growth and effect of do...
Main Authors: | Xiao Cui, Dachen Zhou, Qiang Du, Peiqi Wan, Kun Dong, Hui Hou, David A. Geller |
---|---|
格式: | Article |
語言: | English |
出版: |
Elsevier
2020-10-01
|
叢編: | Translational Oncology |
在線閱讀: | http://www.sciencedirect.com/science/article/pii/S1936523320303004 |
相似書籍
-
Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma.
由: Sameer A Dhayat, et al.
出版: (2015-01-01) -
The microRNA-200 family is upregulated in endometrial carcinoma.
由: Jaime Snowdon, et al.
出版: (2011-01-01) -
MicroRNA‐9 exerts antitumor effects on hepatocellular carcinoma progression by targeting HMGA2
由: Xiangang Xu, et al.
出版: (2019-10-01) -
MicroRNA-200b suppresses the invasion and migration of hepatocellular carcinoma by downregulating RhoA and circRNA_000839
由: Ben-gang Wang, et al.
出版: (2017-07-01) -
Expression and Significance of MicroRNA-183 in Hepatocellular Carcinoma
由: Zenghui Liang, et al.
出版: (2013-01-01)